双鹭药业：目前长效促卵泡审评暂停是因到达审评时限，目前在等待发补意见

Group 1 - The core issue is the suspension of the review for the long-acting follicle-stimulating hormone by the company due to reaching the review deadline and currently awaiting supplementary comments [2]